Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?
- DOI
- 10.1093/braincomms/fcae460
- Published
- 2024-12-18
- Container
- Brain Communications
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/braincomms/fcae460,
title = {Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?},
author = {Lorenzo Pini and Simone Lista and Alessandra Griffa and Gilles Allali and Bruno P Imbimbo},
year = {2024},
journal = {Brain Communications},
doi = {10.1093/braincomms/fcae460},
url = {https://doi.org/10.1093/braincomms/fcae460}
}RIS
TY - JOUR TI - Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs? AU - Lorenzo Pini AU - Simone Lista AU - Alessandra Griffa AU - Gilles Allali AU - Bruno P Imbimbo PY - 2024 JO - Brain Communications DO - 10.1093/braincomms/fcae460 UR - https://doi.org/10.1093/braincomms/fcae460 ER -
APA
Pini, L., Lista, S., Griffa, A., Allali, G., & Imbimbo, B. P. (2024). Can brain network connectivity facilitate the clinical development of disease-modifying anti-Alzheimer drugs?. Brain Communications. https://doi.org/10.1093/braincomms/fcae460
Source records
- crossref · retrieved 2026-09-25T13:26:40.724Z